You take capecitabine and temozolomide as cycles of treatment. This means you take the drugs and then have a rest to allow your body to recover. Each cycle lasts 4 weeks (28 days). You usually have up ...

The role of ADAR1-mediated A-to-I RNA editing and non-editing functions in radioresistance of esophageal squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Patient characteristics and utilization patterns of olaparib in patients with early-stage breast cancer (eBC): Real-world insights using Komodo Healthcare Map (KHM).

The research group led by Professor Martin Green has published Version 66 of the solar cell efficiency tables. There are 17 new results reported in the new version. Furthermore, the tables ...

Even that has been hard to tolerate; she’s had to skip doses because of low white blood cell counts, Alimonti said. She still doesn’t know whether her insurer will cover the test. Around 300,000 ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to shrunken tumors and improved survival, the company announced in ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.

In a phase 3, randomized trial, we enrolled patients with local or regional cutaneous squamous-cell carcinoma, after surgical resection and postoperative radiotherapy, at high risk for recurrence ...

CHICAGO, June 1 (Reuters) - A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal ...